Brugada Syndrome (disorder)
|
0.620 |
GeneticVariation
|
disease |
BEFREE |
Human KCNE5 mutations are associated with atrial fibrillation (AF)- and Brugada syndrome (BrS)-induced cardiac arrhythmias that can arise from increased potassium current in cardiomyocytes.
|
30289750 |
2019 |
Brugada Syndrome (disorder)
|
0.620 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
The human AF-associated mutation KCNE5-L65F negative shifted the voltage dependence of K<sub>V</sub>2.1-KCNE5 channels, increasing their maximum current density >2-fold, whereas BrS-associated KCNE5 mutations produced more subtle negative shifts in K<sub>V</sub>2.1 voltage dependence.
|
30289750 |
2019 |
Brugada Syndrome (disorder)
|
0.620 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Exome analysis in 34 sudden unexplained death (SUD) victims mainly identified variants in channelopathy-associated genes.
|
29350269 |
2018 |
Brugada Syndrome (disorder)
|
0.620 |
Biomarker
|
disease |
CLINGEN |
KCNE4 and KCNE5: K(+) channel regulation and cardiac arrhythmogenesis.
|
27484720 |
2016 |
Brugada Syndrome (disorder)
|
0.620 |
GeneticVariation
|
disease |
ORPHANET |
In 205 Japanese patients with BrS or IVF who tested negative for SCN5A mutation, we conducted a genetic screen for KCNE5 variants.
|
21493962 |
2011 |
Brugada Syndrome (disorder)
|
0.620 |
Biomarker
|
disease |
CLINGEN |
In 205 Japanese patients with BrS or IVF who tested negative for SCN5A mutation, we conducted a genetic screen for KCNE5 variants.
|
21493962 |
2011 |
Brugada Syndrome (disorder)
|
0.620 |
GeneticVariation
|
disease |
BEFREE |
This study investigated whether KCNE5 mutations could be responsible for BrS and other idiopathic ventricular fibrillation (IVF).
|
21493962 |
2011 |
Brugada Syndrome (disorder)
|
0.620 |
Biomarker
|
disease |
CLINGEN |
KCNE1-like gene is deleted in AMME contiguous gene syndrome: identification and characterization of the human and mouse homologs.
|
10493825 |
1999 |
Atrial Fibrillation
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
The human AF-associated mutation KCNE5-L65F negative shifted the voltage dependence of K<sub>V</sub>2.1-KCNE5 channels, increasing their maximum current density >2-fold, whereas BrS-associated KCNE5 mutations produced more subtle negative shifts in K<sub>V</sub>2.1 voltage dependence.
|
30289750 |
2019 |
Atrial Fibrillation
|
0.330 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
The human AF-associated mutation KCNE5-L65F negative shifted the voltage dependence of K<sub>V</sub>2.1-KCNE5 channels, increasing their maximum current density >2-fold, whereas BrS-associated KCNE5 mutations produced more subtle negative shifts in K<sub>V</sub>2.1 voltage dependence.
|
30289750 |
2019 |
Atrial Fibrillation
|
0.330 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Exome analysis in 34 sudden unexplained death (SUD) victims mainly identified variants in channelopathy-associated genes.
|
29350269 |
2018 |
Atrial Fibrillation
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
One-hundred fifty-eight patients with AF were screened for mutations in the coding region of KCNE5.
|
18313602 |
2008 |
Atrial Fibrillation
|
0.330 |
GeneticVariation
|
disease |
LHGDN |
One-hundred fifty-eight patients with AF were screened for mutations in the coding region of KCNE5.
|
18313602 |
2008 |
Atrial Fibrillation
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
Because the KCNE5 gene is located on the X chromosome, the protection conferred by the 97T polymorphism may help explain the gender-related difference in the risk of AF.
|
16054468 |
2005 |
Paroxysmal familial ventricular fibrillation
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
This study investigated whether KCNE5 mutations could be responsible for BrS and other idiopathic ventricular fibrillation (IVF).
|
21493962 |
2011 |
Paroxysmal familial ventricular fibrillation
|
0.310 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Alport Syndrome, Mental Retardation, Midface Hypoplasia, and Elliptocytosis
|
0.300 |
ChromosomalRearrangement
|
disease |
ORPHANET |
|
|
|
Patent ductus arteriosus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Elliptocytosis, Hereditary
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cardiac Arrest
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Muscle hypotonia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Myopia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Paroxysmal ventricular tachycardia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Proteinuria
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Severe intellectual disability
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|